Published on in Vol 12 (2026)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/95949, first published
.

1 Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC, United States
2 Department of Medical Oncology, Highlands Oncology Group, Fayetteville, AR, United States
